CARL NASDAQ
Carlsmed, Inc.
1W: -5.5%
1M: -12.7%
3M: +16.1%
YTD: +22.7%
1Y: +7.1%
$14.27
+0.51 (+3.71%)
Weekly Expected Move ±5.3%
$13
$14
$14
$15
$16
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$387.9M
52W Range8.5-17.23
Volume151,594
Avg Volume132,473
Beta2.09
Dividend—
Analyst Ratings
Company Info
CEOMichael Cordonnier
Employees127
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2025-07-23
Websitecarlsmed.com
1800 Aston Avenue
Carlsbad, CA 92008
US
Carlsbad, CA 92008
US
(760) 766-1923
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Latest News
Carlsmed appoints new CFO, reaffirms 2026 revenue outlook
Carlsmed promotes Jeff Bertolini to COO to support spine surgery growth
BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Price Target at $19.25
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bertolini Jeffrey | S-Sale | 243 | $13.99 | 2026-09-30 |
| Heppenstall Richard | A-Award | 89,286 | — | 2026-09-28 |
| Heppenstall Richard | A-Award | 180,137 | $14.18 | 2026-09-28 |
| Heppenstall Richard | 0 | — | 2026-09-28 | |
| Kamocsay Jennifer | 0 | — | 2026-09-24 |